AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06721494 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methamphetamine
Description: Methamphetamine HCl for intravenous administration
Study NCT06721494 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sterile Saline
Description: Sterile Saline for intravenous administration
Study NCT06721494 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CS-1103
Description: CS-1103 for intravenous administration
Study NCT06720337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.5%
Description: patients will receive 18 ml 0.5% bupivacaine (Sunnypivacaine®) using Ultrasound-Guided TAP Block Technique
Study NCT06367959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Esays
Description: Participants will write about their experiences One (1) time each week for 3 weeks at the beginning of the study and then 1 more time 9 months later. Participants will be asked to write about their experiences with cancer in English or Chinese and to write as much as they can for about 20-30 minutes for each essay.
Study NCT06367959 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Participants will answer a questionnaire at the beginning of the study and then 3, 6, and 12 months later.~Participants will also answer a questionnaire about their thoughts on writing and on the study after they complete the third essay.
Study NCT06720337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: patients will receive plus 0.5 µg/kg of dexmedetomidine (Precedex® 100 µg/ml) diluted in 2 ml of normal saline at each side
Study NCT06720337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MgSO4
Description: patients will receive plus 1.5 mL (150 mg) MgSO4 and 0.5 mL normal saline at each side
Study NCT05820451 — intervention group
Intervention type: DEVICE
Intervention: Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
Description: US commercially approved Abiomed left sided hemodynamic support devices (Impella) will be included.
Study NCT05820451 — intervention group
Intervention type: DEVICE
Intervention: Impella RP with Sodium Bicarbonate used as purge solution
Description: US commercially approved Abiomed right sided hemodynamic support devices (Impella) will be included.
Study NCT05545072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab
Description: Dupilumab will be administered subcutaneously at a dose of 300 milligrams (mg) in a 2 milliliter (mL) solution every 2 weeks until the end of treatment (EOT) at Week 52. Participants will receive a total of 26 doses.
Study NCT05545072 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A placebo to match dupilumab will be administered subcutaneously every 2 weeks until the end of treatment (EOT) at Week 52. Participants will receive a total of 26 doses.
Study NCT05545072 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intranasal Corticosteroid Sprays (INCS)
Description: All participants will undergo standardized background therapy with intranasal corticosteroid sprays (INCS) per standard of care (SoC). This will be continued throughout the entire study. Participants either receive fluticasone propionate or mometasone furoate.
Study NCT05545072 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intranasal Corticosteroid Sprays (INCS)
Description: All participants will undergo standardized background therapy with intranasal corticosteroid sprays (INCS) per standard of care (SoC). This will be continued throughout the entire study. Participants either receive fluticasone propionate or mometasone furoate.
Study NCT06147141 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Peer Companion Intervention
Description: Ordinary children would be paired with ASD children before the interventions. Dyads in the OPCI would have a total of 12 sessions within two months, each lasting 30-60 minutes. The longest interval between two sessions couldn't exceed two weeks. Researchers would recommend a series of companion themes for children to choose from (e.g., daily sharing and drawing). Ordinary children and ASD children need to discuss activities that are of mutual interest before each session. A researcher assistant would be online to ensure the normal development of the interventions and be responsible for video recording of the exchanges at the beginning of each session. Except for extreme circumstances, he or she would turn off the video and sound throughout the process and withdraw soon. During the interventions, parents would play a supporting role when children express needs without over-involvement.
Study NCT06353581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neulapeg
Description: Participants will receive Neulapeg subcutaneously 24 hours after the end of modified FOLFIRINOX dosing. (Must be administered within a maximum of 72 hours; Neulapeg will only be given for up to 8 cycles).
Study NCT06353581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Patients assigned to the non-Neulapeg arm will be crossover to Neulapeg if they develop grade 3-4 neutropenia or neutropenic fever. Crossover subjects will receive up to 8 cycles of Neulapeg as a secondary treatment regardless of starting cycle.
Study NCT05751824 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AI based automatic surveillance (AS) system (ENDOANGEL-AS)
Description: An automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times.
Study NCT05751824 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Manually remind the patients to review.
Description: Medical staff remind patients to review by telephone.
Study NCT06648408 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Balett Training
Description: The ballet training will happen twice a week for six weeks, with each session lasting 60 minutes, for a total of 12 sessions. These sessions will be held in groups of 10 to 12 children and led by experienced ballet teachers. The classes will follow a beginner-level ballet routine, introducing the kids to ballet techniques in a fun and playful way, making sure they learn the movements step by step. Each lesson will follow the same structure, allowing the children to improve their skills week after week. In addition to the group sessions, the children will be given a 10-minute daily home exercise program. This will include simple ballet exercises they learned in their first class, which they should practice on the five days when they don't have ballet sessions. The children will track their practice in a child-friendly diary designed just for them.
Study NCT06653491 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: high-speed, low-amplitude talocrural decompression technique and changes at the level of mobility and plantar pressure
Description: high-speed, low-amplitude talocrural decompression technique and changes at the level of mobility and plantar pressure in a supine position
Study NCT06653491 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: simulated ankle technique
Description: simulated ankle technique in a supine position
Study NCT05910268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: NIATx + ECHO
Description: Project ECHO will be combined with NIATx to provide clinical skills to PHC staff and delivered in a hub and spoke model to connect SHC and PHC staff in delivery of HIV care. Decentralization will occur through guideline concordance, facilitated through NIATx and ECHO.
Study NCT06418789 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles )
Description: TI: Paclitaxel 200mg/m² on day 1, Ifosfamide 2000mg/m² daily from days 1 to 3 of 14-day cycle. G-CSF 10 micrograms/Kg SC daily day on days 6-14 day or until CD34 harvest. Leukapheresis will be performed starting on day 11 in case blood level of CD45+CD34+ above 20x10\^6/L is achieved.~CE: Carboplatin AUC=8 IV daily days -4 to -2, Etoposide 400mg/m\^2 IV daily days -4 to -2, autlologous stemm cell transplantation >=2\*10\^6/Kg at day 0, GCSF support from day 4 until the recovery of neutrophils above 1\*10\^9/L.~Patients will receive two cycles of TI followed by 3 cycles of CE in case at least 6\*10\^6 CD34+ stem cells will be harvested.
Study NCT06147141 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Wait-List
Description: Dyads in the WLG would only participate in preliminary training and measurement during the implementation of the intervention. After completing the post-test, this study will implement the same online peer companionship intervention.
Study NCT05189119 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: non invasive ventilation
Description: invasive mechanical ventilation session in the BIPAP Mode with a pressure support (PS) level of 5cmH2O, a positive end expiratory pressure (PEEP) level of 5 cmH2O and an inspiratory fraction of oxygen (FiO2) allowing a pulse saturation (SpO2) of at least 92% for a one minute and followed by an increase of the PS level to 30cmH2O.The plethysmographic PAR (PAR) was calculated based on the following formula: PARpleth= PP30 / PP5
Study NCT06527781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD5K3
Description: Six dose levels will be evaluated. intravenous injection
Study NCT06527781 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: intravenous injection
Study NCT06527781 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pegaspargase
Description: Six dose levels will be evaluated. intramuscular injection
Study NCT06503809 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Participants will consume a very-low-carbohydrate ketogenic diet for 26 weeks.
Study NCT06503809 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Diet
Description: Participants will consume an American Diabetes Association-recommended standard diet for 26 weeks.
Study NCT04967677 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Nine Hole Peg Test, Purdue Pegboard Test, Box and Block Test
Description: At first, each person will be asked to fill in the questionnaire. Than he/she will be tested by the Nine Hole Peg Test, Purdue Pegboard Test and the Box and Block Test according to the Czech version of extended manuals for those tests. Audio recording of verbal instructions will be used.
Study NCT06374186 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention with financial rewards and coaching
Description: Participants will receive variable financial incentives based on their engagement with the continuous glucose monitor and meeting diabetes treatment goals. In addition, they will participate in three motivational interviewing sessions focused on their diabetes management. Participants will continue to receive their diabetes treatment as usual.
Study NCT06374186 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Participants will only receive a continuous glucose monitor, which they may engage with as desired and no further intervention. Participants in the control group will continue to receive their diabetes treatment as usual.
Study NCT06090760 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: Mindfulness is paying attention in a particular way: on purpose, in the present moment, and non-judgmentally (Kabat-Zinn 1994, 4) and has five facets: awareness, nonjudgement, nonreactive, observe, and describe (Baer et al., 2006).
Study NCT06119113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of the wound infection at the 10th day post-op check-up among all groups
Description: Discharge, redness, increased temperature, and dehiscence were accepted as wound infection.
Study NCT06213376 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Melodic Intonation Therapy
Description: Melodic Intonation Therapy uses intonation and melody to aid individuals with aphasia with producing words.
Study NCT06213376 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video Feedback Performance Review
Description: Participant will view recording to judge correct and incorrect productions of trained words and to identify motor techniques increasing intelligibility
Study NCT05963542 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT for tinnitus
Description: The intervention will be based on the ACT model and adjusted for tinnitus.
Study NCT05963542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Customized sound therapy
Description: The music will be modulated through a smartphone app using a set program to generate customized tinnitus relieving sound.
Study NCT05963542 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Customized sound therapy
Description: The music will be modulated through a smartphone app using a set program to generate customized tinnitus relieving sound.
Study NCT05230823 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CR with added BWLT
Description: 12 week outpatient cardiac rehab (CR) program consisting of twice-weekly supervised exercise and risk factor modification (e.g. smoking cessation, support with medication). Concurrently, the patients will attend a weekly behavioural weight loss treatment (BWLT). Weekly goal-setting facilitated by the interventionist will focus on behavioural changes in nutrition and moderate calorie reduction while also emphasizing physical activity consistent with an individualized CR exercise prescription. Patients will track caloric intake, weekly exercise, weekly weight, and success/challenges with other health goals (e.g., challenging negative thoughts, body image, mindful eating, etc.) using a daily health diary. ASPIRE-AF will be delivered virtually to small groups (8-12 patients) by senior PhD students with advanced training in cognitive-behavioural therapy and motivational communication principles.
Study NCT05451641 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blood flow restriction resistance training
Description: The participants will receive a 2-week exercise training program (3 times per week). Each training session will consist of 3 resistance training exercises with two blood flow restriction devices (wide-rigid cuff and narrow-elastic band). For both arms, the participants will perform the same exercise with different BFR devices.
Study NCT05489770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Sambucol® Black Elderberry Original (Sambucus nigra) Liquid
Description: Sambucol® Black Elderberry Original (Sambucus nigra) Liquid has been used as a supplement since 1991 with no reports of adverse effects received by the Manufacturer.
Study NCT05489770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo for Sambucol® Black Elderberry Original (Sambucus nigra)
Description: Placebo for Sambucol® Black Elderberry Original (Sambucus nigra) Liquid Constituents: 70% (w/w) of glucose syrup, Flavouring agent: Elderberry Blossom
Study NCT05888103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inclisiran
Description: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran\*) in 1.5 mL
Study NCT05888103 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo for Inclisiran
Description: Matching s.c. placebo in 1.5 mL
Study NCT06119113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of the cosmetic results of the incision line at the 2nd month post-op check-up among all groups
Description: The cosmetic outcome of wound site scar healing was evaluated with two different scales. The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality. The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area. The participant scores six items: pain, itching, color, thickness, relief, and flexibility. All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'. All items are summed to determine the total scar score; a higher score represents worse scar quality. The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation. The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Study NCT04558073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Body Project (BP)
Description: The BP intervention offers discussions and exercises to make participants realize the cost of pursuing social ideals valuing thinness. This produces cognitive dissonance, a cognitive discomfort due to a contradiction between speech and beliefs, which motivates to modify one's beliefs. The curriculum includes discussions on techniques of the advertising industry and the unique ideal of beauty promoted worldwide, as well as on the costs of pursuing the thin-ideal. Participants are also challenged to try behaviours they avoid because their appearance bother them. Societal activism actions are also discussed.
Study NCT06119113 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of the cosmetic results of the incision line at the 6th month post-op check-up among all groups
Description: The cosmetic outcome of wound site scar healing was evaluated with two different scales. The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality. The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area. The participant scores six items: pain, itching, color, thickness, relief, and flexibility. All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'. All items are summed to determine the total scar score; a higher score represents worse scar quality. The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation. The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Study NCT04558073 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Weight Program (HW)
Description: The HW intervention allows participants to make personalized changes in their diet and physical activity each week gradually, to aim for a health-ideal rather than a thin-ideal. The intervention is based on small changes, based on behavioural change techniques. Advice is given on what types of changes introduce to promote health, and how to implement changes sustainably. Difficulties are discussed in the group with a problem-solving approach. The last session introduces a long-term view of lifestyle change.
Study NCT05758870 — intervention group
Intervention type: PROCEDURE
Intervention: surgical stabilization of low rib fratures
Description: surgical stabiliazation of rib fractures by internal fixation
Study NCT05880381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Group
Description: Patients allocated to the treatment group will undergo an intervention that comprises 3 weekly sessions of 60 minutes for 4 weeks with the VR prototype.
Study NCT05880381 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: The participants allocated to this group will do the formal standard care provided by the Gynecology- Obstetric service.
Study NCT05813964 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TDF/FTC 300mg/200mg fixed-dose combination tablets
Description: Event-driven dosing regimen
Study NCT05813964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAF/FTC 25mg/200mg fixed-dose combination tablets
Description: Event-driven dosing regimen.
Study NCT06530199 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative
Description: connective tissue graft and Enamel matrix derivative in the defect area
Study NCT06530199 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Enamel matrix derivative
Description: connective tissue graft and Enamel matrix derivative in the defect area
Study NCT06434181 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot Juice
Description: Beet-It Sports Shot, 70mL, containing 6.5 mmol nitric oxide (taking two shots per day in active group)
Study NCT06434181 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control
Description: Beet-It Placebo Shot, 70mL (taking two shots per day in placebo group)
Study NCT00378781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Heparin
Description: Heparin flush solution into CVC once daily.
Study NCT00378781 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Minocycline-EDTA
Description: M-EDTA flush solution into CVC once daily.
Study NCT05272475 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chamomile Tea
Description: Chamomile tea bags consumed by subjects as described in study arms section.
Study NCT05272475 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chamomile Extract Capsule
Description: Chamomile extract capsules consumed by subjects as described in Experimental: Chamomile Extract Capsule study arms section.
Study NCT04884152 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Group
Description: Educational training program about bruxism and the other oral parafunctional activities in patients with myofascial temporomandibular disorders.
Study NCT04884152 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Group
Description: Telerehabilitation program combined with educational training program about bruxism and the other oral parafunctional activities in patients with myofascial temporomandibular disorders.